In the present study, pretreatment of osteosarcoma cells with a miR-4463 mimic reversed FGF-23-mediated LOXL2 expression downstream of ERK, p38, and JNK signaling, and suppressed the enhanced migratory ability of osteosarcoma cells in vitro. The gene discussed is LOXL2; the disease is osteosarcoma.